Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision: v3.6.3 is now displayed, signaling a minor update to the page content or metadata since the previous revision (v3.6.2). The change does not affect the study data or eligibility.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded a 2026 publication by Paller et al. reporting ECZTRA 6 results in Dermatol Ther (Heidelb) and removed the earlier 'Online ahead of print' citation dated Apr 25, 2026 (doi: 10.1007/s13555-026-01745-7). The page revision was updated to v3.6.2.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page adds new user guidance pages (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the header from 'Intervention / Treatment' to 'Intervention/Treatment', while updating the revision to v3.6.0.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata. The change does not alter any study information or content presented to users.SummaryDifference0.0%

- Check57 days agoChange Detected- The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend or documentation update behind the scenes. - No substantive changes to the study details or visible content are implied by this revision.SummaryDifference0.0%

- Check72 days agoChange DetectedA new publication reference was added under Publications, citing a 2026 online-ahead-of-print article by Paller et al. on clinical laboratory parameters in adolescents with moderate-to-severe atopic dermatitis treated with tralokinumab in ECZTRA 6. This entry expands the study's related literature linked to ECZTRA 6.SummaryDifference0.0%

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.